.
DURECT is headquartered in Cupertino, California.
DURECT disclosed revenue of 9M USD for 2023 and 19M USD for 2022.
DURECT is a life science company.
DURECT was founded in 1988.
Join Mergr to view all 0 acquisitions of life science companies in , including .
10240 Bubb Road,
Cupertino, California
95014
United States,
(408) 777-1417
www.durect.com
DURECT is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. DURECT was founded in 1988 and is based in Cupertino, California.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.2/yr) | # | - | - | - | - | - | 1 | 1 |
| vol | $18M | $18M | ||||||
| 1 | ||||||||
| Company | Date | Value | Type |
|---|---|---|---|
| Alzet LLC | 2024-11-25 | 18M USD | Divestiture |
| Cupertino, California · www.alzet.com | |||
| View All >> | |||
| Sector | Buy # | Value | Sell # | Value | |
|---|---|---|---|---|---|
| Medical Products | - | - | 1 (100%) | 18M (100%) | |
| Total | - | - | 1 | $18M | |
| State/Country | Buy | Value | Sell | Value | ||
|---|---|---|---|---|---|---|
| United States | - | - | 1 | 18M | ||
| California | - | - | 1 | 18M | ||
| Total | - | - | 1 | $18M | ||
| Financial | Deals |
|---|---|
|
Aquilo Partners LP |
1 |
| Legal | Deals |
|---|---|
|
Wilson Sonsini Goodrich & Rosati |
1 |
| sell | # | Total |
|---|---|---|
| < $100M | 1 | $18M |
| TOTAL | $18M | |
| Largest |
Alzet LLC $18M (2024-11-25) |
|
| Deals | ||
|---|---|---|
| Divested to | ||
| Strategic(s) |
|
1 (100%) |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
